Top of page
Global Site Navigation

Staff

Local Section Navigation
You are here: Main Content

Clinical Associate Professor Daphne Tsoi

Adjunct Associate Professor

Staff Member Details
Email: t.daphne@ecu.edu.au

Associate Professor Daphne Tsoi is a medical oncologist and Adjunct Associate Professor at ECU’s Exercise Medicine Research Institute.

Background

Associate Professor Daphne Tsoi is a local medical graduate who completed her Medical Oncology training in Western Australia. She then undertook a two-year Breast Cancer Clinical Research Fellowship at Sunnybrook Odette Cancer Centre (Toronto, Canada), and obtained a Master of Science degree in Clinical Epidemiology at the University of Toronto.  She continues her interest in Breast Cancer research and has a number of publications in peer-reviewed journals.  She is the director of the Murdoch Oncology Clinical Trials Unit, and is a principal investigator for a number of international trials.  She is an adjunct associate professor at the University of Notre Dame Australia.  She has private practice at St John of God Hospitals at Murdoch and Subiaco. Besides breast cancer, her other interests include brain tumours, colorectal and lung cancers. Dr Tsoi is also a key clinical collaborator in many research trials requiring medical oncologist through-put as an adjunct Associate Professor at the Exercise Medicine Research Institute (Edith Cowan University).

Research Areas and Interests

  • Medical Oncology
  • Breast Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Exercise Oncology

Research Outputs

Journal Articles

  • Hart, N., Galvao, D., Saunders, C., Taaffe, D., Feeney, K., Spry, N., Tsoi, D., Martin, H., Chee, R., Clay, T., Redfern, A., Newton, R. (2018). Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine. Trials, 19(1), Article no.695. https://doi.org/10.1186/s13063-018-3091-8.
Skip to top of page